Mutational status of TP53 defines the efficacy of Wee1 inhibitor AZD1775 in KRAS-mutant non-small cell lung cancer

标题
Mutational status of TP53 defines the efficacy of Wee1 inhibitor AZD1775 in KRAS-mutant non-small cell lung cancer
作者
关键词
NSCLC, Wee1, AZD1775, KRAS, TP53
出版物
Oncotarget
Volume 8, Issue 40, Pages -
出版商
Impact Journals, LLC
发表日期
2017-06-28
DOI
10.18632/oncotarget.18728

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started